why Appendix XI submitted along with CIOMS to EC

Appendix XI


According to Schedule y the safety reports should be sent to regulatory authorities with in 15 days.Incase if the event experienced by the indian population Appendix XI should be submitted along with CIOMS form.

Data Elements for reporting serious adverse events occuring in a clinical trial



1. Patient Details



Initials & other relevant identifier (hospital/OPD record number etc.)*

Gender

Age and/or date of birth

Weight

Height



2. Suspected Drug(s)



Generic name of the drug*

Indication(s) for which suspect drug was prescribed or tested

Dosage form and strength

Daily dose and regimen (specify units - e.g., mg, ml, mg/kg)

Route of administration

Starting date and time of day

Stopping date and time, or duration of treatment



3. Other Treatment(s)



Provide the same information for concomitant drugs (including non prescription/OTC drugs) and non-drug therapies, as for the suspected drug(s).



4. Details of Suspected Adverse Drug Reaction(s)



Full description of reaction(s) including body site and severity, as well as the criterion (or criteria) for regarding the report as serious. In addition to a description of the reported signs and symptoms, whenever possible, describe a specific diagnosis for the reaction.*



Start date (and time) of onset of reaction

Stop date (and time) or duration of reaction

Dechallenge and rechallenge information

Setting (e.g., hospital, out-patient clinic, home, nursing home)



5. Outcome

Information on recovery and any sequelae; results of specific tests and/or treatment that may have been conducted

For a fatal outcome, cause of death and a comment on its possible relationship to the suspected reaction; Any post-mortem findings.


Other information: anything relevant to facilitate assessment of the case, such as medical history including allergy, drug or alcohol abuse; family history; findings from special investigations etc.



6. Details about the Investigator*

Name

Address

Telephone number

Profession (specialty)



Date of reporting the event to Licensing Authority:

Date of reporting the event to Ethics Committee overseeing the site:



Signature of the Investigator

Note: Information marked * must be provided.”

Site visit with the sponsor

Effective_site_visit_with_sponsor -

GCP Compliance check list

GCP_compliance_checklist[1] -

IRB submission checklist

IRB_submission_Checklist[1] -

Monitoring plan

JCTO+TEMPLATE+Monitoring+Plan+Version+1.0_2C+07OCT08[1] -

Informed consent

InformedConsent-clinicalstudies[1] -

Clinical Research book

1_ClinicalTrials manual from the Dukes clinical Research Institute -